VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASIC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ASICAtegrity Specialty Holdings LLC
$24.78$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksASICQuarterly Financials

Ategrity Specialty Holdings LLC (ASIC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ategrity Specialty Holdings LLC (ASIC) quarterly income statement — complete revenue, gross profit & net income history

ASIC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q1'24
Revenue128.96M123.34M116.1M101.78M83.12M76.07M
Revenue Growth %55.15%---9.27%-
Medical Costs & Claims61.88M27.99M56.2M66.5M61.46M56.01M
Medical Cost Ratio %47.98%22.69%48.41%65.34%73.94%73.63%
Gross Profit67.08M95.35M59.9M35.28M21.66M20.06M
Gross Margin %52.02%77.31%51.59%34.66%26.06%26.37%
Gross Profit Growth %209.69%---7.99%-
Operating Expenses32.85M62.19M30.17M12.95M10.97M9.03M
OpEx / Revenue %25.48%50.42%25.98%12.72%13.2%11.87%
Depreciation & Amortization000000
Combined Ratio %73.46%73.11%74.39%78.06%87.14%85.5%
Operating Income34.23M33.16M29.73M22.33M10.69M11.03M
Operating Margin %26.54%26.89%25.61%21.94%12.86%14.5%
Operating Income Growth %220.2%----3.06%-
EBITDA34.23M33.23M30.13M22.78M11.14M11.58M
EBITDA Margin %26.54%26.94%25.95%22.38%13.4%15.22%
Interest Expense4K72K392K447K447K550K
Non-Operating Income-4K-72K-392K-447K-447K-550K
Pretax Income34.23M33.16M29.73M22.33M10.69M11.03M
Pretax Margin %26.54%26.89%25.61%21.94%12.86%14.5%
Income Tax7.05M6.71M6.12M4.71M2.24M2.07M
Effective Tax Rate %20.6%20.24%20.58%21.11%20.95%18.77%
Net Income25.47M25.26M22.66M17.62M8.46M7.76M
Net Margin %19.75%20.48%19.52%17.31%10.18%10.2%
Net Income Growth %200.99%---9.09%-
EPS (Diluted)0.510.510.450.400.170.16
EPS Growth %200%---6.25%-
EPS (Basic)0.530.530.470.420.170.16
Diluted Shares Outstanding49.77M49.76M45.05M42.25M48.46M48.46M